- SG$25.83m
- SG$55.17m
- SG$232.03m
- 50
- 100
- 22
- 61
Annual income statement for mDR, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 193 | 189 | 175 | 216 | 232 |
| Cost of Revenue | |||||
| Gross Profit | 24.3 | 24.9 | 27.5 | 32.6 | 41 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 206 | 184 | 165 | 255 | 224 |
| Operating Profit | -13.4 | 5.27 | 10.7 | -38.9 | 8.24 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -14.5 | 4.3 | 9.26 | -42 | 5.73 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -14.4 | 4.08 | 9.18 | -42.5 | 5.48 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -14.3 | 4.08 | 7.26 | -42.5 | 5.49 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -14.3 | 4.08 | 7.26 | -42.5 | 5.49 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.005 | 0.003 | 0.009 | -0.013 | 0.02 |
| Dividends per Share |